The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with acute mountain sickness susceptibility: A meta-analysis

High Altitude Medicine and Biology

Volumn 13, Issue 4, 2012, Pages 252-257

  Luo, Yongjun ^a,b   Chen, Yu ^a,b   Zhang, Yao ^a   Gao, Yuqi ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Key Laboratory of High Altitude Physiology and High Altitude Diseases   (China)

Author keywords

acute mountain sickness; Angiotensin converting enzyme; association; insertion deletion polymorphism; meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE DISEASE; ALLELE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ANOREXIA; ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DIZZINESS; DNA POLYMORPHISM; FATIGUE; GENETIC MODEL; HEADACHE; HUMAN; INDEL MUTATION; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; SLEEP DEPRIVATION; VOMITING;

ACUTE DISEASE; ALTITUDE SICKNESS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, STATISTICAL; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION;

EID: 84876359870     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2012.1014     Document Type: Article

References (31)

1. Bartsch P, Shaw S, Franciolli M, Gnadinger MP, Weidmann P. (1988). Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 65:1929-1937. (Pubitemid 19012291)
2. Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Ge M, Fan LP, Zhu WZ, Portman MA et al. (2010). Genetic associations with mountain sickness in Han and Tibetan residents at the Qinghai-Tibetan Plateau. Clin Chim Acta 411:1466-1473.
3. Cargill RI, Lipworth BJ. (1996). Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 109:424-429. (Pubitemid 26058600)
4. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. (1989). DNA polymorphisms at the lipoprotein lipase gene: Associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 79:85-91. (Pubitemid 19219633)
5. Dehnert C, Weymann J, Montgomery HE, Woods D, Maggiorini M, Scherrer U, Gibbs JS, Bartsch P. (2002). No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 34:1928-1933. (Pubitemid 35440412)
6. Ding H, Liu Q, Hua M, Ding M, Du H, Zhang W, Li Z, Zhang J. (2011). Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness. Respiration 81:236-241.
7. Droma Y, Ota M, Hanaoka M, Katsuyama Y, Basnyat B, Neupane P, Arjyal A, Pandit A, Sharma D, Ito M, et al. (2008). Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. Aviat Space Environ Med 79:1056-1060.
8. Hackett PH, Rennie D, Hofmeister SE, Grover RF, Grover EB, Reeves JT. (1982). Fluid retention and relative hypoventilation in acute mountain sickness. Respiration 43:321-329. (Pubitemid 12024407)
9. Hennis PJ, Bussell C, Darlison MG. (2010). The lack of associations between alleles at the hypoxia-inducible factor 1A C1772T loci and responses to acute hypoxia. Wilderness Environ Med 21:219-228.
10. Kalson NS, Thompson J, Davies AJ, Stokes S, Earl MD, Whitehead A, Tyrrell-Marsh I, Frost H, Montgomery H. (2009). The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m). Eur J Appl Physiol 105:373-379.
11. Koehle MS, Wang P, Guenette JA, Rupert JL. (2006). No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt Med Biol 7:281-289. (Pubitemid 46099760)
12. Loeppky JA, Icenogle MV, Maes D, Riboni K, Hinghofer-Szalkay H, Roach RC. (2005). Early fluid retention and severe acute mountain sickness. J Appl Physiol 98:591-597. (Pubitemid 40129970)
13. Luo Y, Chen Y, Zhou Q, Hou X, Gao Y. (2011). A survey of acute mountain sickness and vital signs in subjects ascending to Lhasa via the Qinghai-Tibet train. Sci Res Essays 6:2639-2645.
14. Ma X, Chen C, Xiong H, Li Y. (2010). Transforming growth factor-beta1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: Evidence from 10,392 cases and 11,697 controls. Breast Cancer Res Treat 124:453-457.
15. Maggiorini M, Muller A, Hofstetter D, Bartsch P, Oelz O. (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 69:1186-1192. (Pubitemid 28544217)
16. Mantel N, Haenszel W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
17. Morrell NW, Atochina EN, Morris KG, Danilov SM, Stenmark KR. (1995a). Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxiainduced pulmonary hypertension. J Clin Invest 96:1823-1833.
18. Morrell NW, Morris KG, Stenmark KR. (1995b). Role of angiotensin- converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269:H1186-1194.
19. Norihiro K, Yuki T, Osamu N. (2002). The change of serum angiotensin-converting enzyme level during staying at high Altitude[Japan]. Jap J Mountain Med 22:79-82.
20. Pasha MA, Khan AP, Kumar R, Ram RB, Grover SK, Srivastava KK, Selvamurthy W, Brahmachari SK. (2002). Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 27:67-70. (Pubitemid 34285620)
21. Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van Someren K, Montgomery HE. (2011). The ACE gene and human performance: 12 years on. Sports Med 41:433-448.
22. Qi Y, Sun J, Zhu T, Wang W, Liu J, Zhou W, Qiu C, Zhao D. (2011). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with high-altitude pulmonary oedema: A meta-analysis. J Renin Angiotensin Aldosterone Syst 12:617-623.
23. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346. (Pubitemid 20370444)
24. Roach RC, Oelz O, Hackett PH. (1993). The Lake Louise acute mountain sickness scoring system. Hypoxia Mol Med 272-274.
25. Slager SL, Schaid DJ. (2001). Case-control studies of genetic markers: Power and sample size approximations for Armitage's test for trend. Hum Hered 52:149-153. (Pubitemid 34701500)
26. Thomassen O, Skaiaa SC. (2007). High-altitude cerebral edema with absence of headache. Wilderness Environ Med 18:45-47. (Pubitemid 46536964)
27. Walker E, Hernandez AV, Kattan MW. (2008). Meta-analysis: Its strengths and limitations. Cleve Clin J Med 75:431-439.
28. Wang P, Koehle MS, Rupert JL. (2007). Common haplotypes in the beta-2 adrenergic receptor gene are not associated with acute mountain sickness susceptibility in Nepalese. High Alt Med Biol 8:206-212. (Pubitemid 47403504)
29. Wang P, Koehle MS, Rupert JL. (2009). Genotype at the missense G894T polymorphism (Glu298Asp) in the NOS3 gene is associated with susceptibility to acute mountain sickness. High Alt Med Biol 10:261-267.
30. Wang P, Koehle MS, Rupert JL. (2010). No association between alleles of the bradykinin receptor-B2 gene and acute mountain sickness. Exp Biol Med (Maywood) 235:737-740.
31. Zhou F, Wang F, Li F, Yuan J, Zeng H, Wei Q, Tanguay RM, Wu T. (2005). Association of hsp70-2 and hsp-hom gene polymorphisms with risk of acute high-altitude illness in a Chinese population. Cell Stress Chaperones 10:349-356. (Pubitemid 41813382)